NYSE ARCA | ETF
The fund generally will invest at least 90% of its total assets in securities that comprise the underlying index.
The underlying index was composed of common stocks ofU. S. biotechnology and genome companies.
These companies are engaged principally in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes, etc.
It is non-diversified.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| ALNY | Alnylam Pharmaceuticals Inc | Healthcare | Biotechnology | 7.07% |
| ILMN | Illumina Inc | Healthcare | Diagnostics & Research | 5.80% |
| RPRX | Royalty Pharma Plc | Healthcare | Biotechnology | 5.68% |
| NTRA | Natera Inc | Healthcare | Diagnostics & Research | 5.40% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 5.26% |
| BMRN | Biomarin Pharmaceutical Inc | Healthcare | Biotechnology | 5.22% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 5.05% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 4.79% |
| IMGN | ImmunoGen Inc | Healthcare | Biotechnology | 4.78% |
| UTHR | United Therapeutics Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 4.74% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 4.12% |
| AVXL | Anavex Life Sciences Corp | Healthcare | Biotechnology | 3.95% |
| AXSM | Axsome Therapeutics Inc | Healthcare | Biotechnology | 3.73% |
| REGN | Regeneron Pharmaceuticals Inc | Healthcare | Biotechnology | 3.55% |
| BPMC | Blueprint Medicines Corp | Healthcare | Biotechnology | 3.32% |
| INCY | Incyte Corporation | Healthcare | Biotechnology | 3.18% |
| IONS | Ionis Pharmaceuticals Inc | Healthcare | Biotechnology | 3.13% |
| PTGX | Protagonist Therapeutics Inc | Healthcare | Biotechnology | 3.10% |
| ALKS | Alkermes Plc | Healthcare | Drug Manufacturers - Specialty & Generic | 3.05% |
| DVAX | Dynavax Technologies Corporation | Healthcare | Drug Manufacturers - Specialty & Generic | 3.04% |